Last reviewed · How we verify
NCT06726486
Use of a Hypercaloric and Hyperprotein Supplement Enriched with Immunonutrients in Multi-pathological Malnourished Patients to Improve the Incidence and Prevalence of Pressure Sores
Phase 4 trial testing Atémpero in Multimorbidity in 69 participants. Completed in 30 April 2023.
30 April 2023
Quick facts
| Lead sponsor | University of Cadiz |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 69 |
| Start date | 1 January 2022 |
| Primary completion | 30 April 2023 |
| Estimated completion | 30 April 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Atémpero
- Control (Standard treatment) — full drug profile →
Conditions studied
- Multimorbidity — all drugs for Multimorbidity →
- Comorbidity — all drugs for Comorbidity →
- Malnutrition — all drugs for Malnutrition →
- Pressure Ulcer Prevention — all drugs for Pressure Ulcer Prevention →
Sponsor
University of Cadiz
Who can join
Eligibility, any sex, with Multimorbidity or Comorbidity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to evaluate the efficacy of a hypercaloric, hyperproteic enteral formula enriched with immunonutrients in preventing and treating pressure injuries in hospitalized malnourished patients. Participants will take enteral formula (a complete hyperproteic and hypercaloric oral nutritional supplement with a fibre mixture enriched in omega 3, L-arginine and nucleotides, providing vitamin C and Zinc) or a hyperproteic and hypercaloric oral nutritional supplement with fibre mixture every day for 30 days.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06726486
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Multimorbidity
Currently open trials in the same condition.
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
- NCT06605807 — Optimizing Prescribing Decisions for Hospitalized Older Adults With Chronic Conditions · NA · recruiting
- NCT07211750 — Integrated Care for Older Adults With Major Depression and Physical Multimorbidity - The I-CONNECT · NA · recruiting
- NCT07205692 — Multimorbidity and Cardiovascular Risk Factors After Renal Transplant · recruiting
- NCT06975501 — Community-Empowerment and Environmental Enrichment-based Co-management (CEEEC) Model and Mechanisms for Improving Health · NA · active not recruiting
Other University of Cadiz trials
Trials by the same sponsor.
- NCT07584343 — EMG of Gait Under Dual-Task in Parkinson Desease · completed
- NCT07267468 — Effectiveness of an mHealth Intervention, Based on Rehabilitation and a Personalised Nutrition Plan, in the Recovery and · NA · recruiting
- NCT07251322 — Relationship Between Frailty and Gut Microbiota in Older Adults: An Educational Program for Healthy Aging · completed
- NCT06729138 — Resisted Training in Runners · NA · completed
- NCT06871072 — Telerehabilitation for Multiple Sclerosis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06726486 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Cadiz
- Last refreshed: 10 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06726486.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing